SCINAI IMMUNOTHERAPEUTICS LT (SCNI) Stock Income Statement
NASDAQ:SCNI - Nasdaq - US09073Q3039 - ADR - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 658.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Cost Of Goods | 1.24M | N/A | N/A | N/A | N/A | |||
| Gross Profit | -580.00K | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 8.06M | 9.71M | 11.06M | 10.78M | -2.13M | |||
| Research and Development | 5.53M | 5.21M | 5.76M | 2.62M | 14.42M | |||
| Selling, General, and Administrative Expenses | 2.53M | 4.50M | 5.30M | 7.42M | 4.69M | |||
| Operating Income | -8.64M | -9.71M | -11.06M | -10.78M | 2.13M | |||
| Interest Income/Expense | -1.32M | 3.21M | 5.26M | -1.59M | -3.43M | |||
| Non Recurring Items | 14.76M | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | 4.80M | -6.50M | -5.80M | -12.38M | -1.30M | |||
| Net Income | 4.80M | -6.50M | -5.80M | -12.38M | -1.30M | |||
| EBITDA | -6.99M | -9.19M | -10.50M | -10.04M | 2.84M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 7.94 | 0.00 | -52.94 | -1.16K | -158.82 | |||
| Non GAAP EPS | N/A | -18.70 | N/A | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | -88.15% | N/A | N/A | N/A | N/A | |||
| Profit Margin | 728.88% | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | -1312.77% | N/A | N/A | N/A | N/A | |||
All data in USD